Display options
Cite
Desiere F, Romano Spica V. Personalised medicine in 2012: editorial to the special issue of New Biotechnology on "molecular diagnostics & personalised medicine". N Biotechnol. 2012;29(6):611-2doi: 10.1016/j.nbt.2012.03.010.
Desiere, F., & Romano Spica, V. (2012). Personalised medicine in 2012: editorial to the special issue of New Biotechnology on "molecular diagnostics & personalised medicine". New biotechnology, 29(6), 611-2. https://doi.org/10.1016/j.nbt.2012.03.010
Desiere, Frank, and Romano Spica, Vincenzo. "Personalised medicine in 2012: editorial to the special issue of New Biotechnology on "molecular diagnostics & personalised medicine"." New biotechnology vol. 29,6 (2012): 611-2. doi: https://doi.org/10.1016/j.nbt.2012.03.010
Desiere F, Romano Spica V. Personalised medicine in 2012: editorial to the special issue of New Biotechnology on "molecular diagnostics & personalised medicine". N Biotechnol. 2012 Sep 15;29(6):611-2. doi: 10.1016/j.nbt.2012.03.010. Epub 2012 Apr 05. PMID: 22504736.
Copy Download .nbib Format: NLM
Share it on

N Biotechnol. 2012 Sep 15;29(6):611-2. doi: 10.1016/j.nbt.2012.03.010. Epub 2012 Apr 05.

Personalised medicine in 2012: editorial to the special issue of New Biotechnology on "molecular diagnostics & personalised medicine".

New biotechnology

Frank Desiere, Vincenzo Romano Spica

PMID: 22504736 DOI: 10.1016/j.nbt.2012.03.010

Abstract

This special issue of New Biotechnology is focused on molecular diagnostics and personalised medicine and appears at an epochal moment in the development of the field. The practice of medicine is taking a significant and irrevocable turn towards personalisation, due to the great progress in areas such as genomics, pharmacogenomics and molecular diagnosis. It becomes increasingly apparent that to deliver the promise of personalised treatments, more and more novel medicines discovered today will be presented together with innovative companion diagnostics. The contributions to this volume touch on many disciplines, ranging from cell biology to genetics, immunology, molecular diagnostics, pharmaceutics and economic issues. The contributions of clinicians and basic scientists are synergistically presented to underline better the wide spectrum of studies that can contribute to the new field of personalised medicine. The promising perspectives of individualised treatments are related not only to higher effectiveness, but also to increased efficiency. This is relevant not only for the individual patient, but even more so for the general public, within a wider economical perspective where resources are limited and it becomes more and more mandatory to close the gap between social costs and benefits. This approach follows the steps of a stratified and individualised medicine and finds its final goal in an individualised healthcare.

Copyright © 2012 Elsevier B.V. All rights reserved.

MeSH terms

Publication Types